Azafaros begins subject enrolment in Phase II RAINBOW trial of AZ-3102

Azafaros begins subject enrolment in Phase II RAINBOW trial of AZ-3102

Submitted by admin on June 9, 2023 - 10:11am
Source: 
Clinical Trials Arena
News Tags: 
Azafaros
AZ-3102
Niemann-Pick disease
GM2 gangliosidosis
clinical trials
Headline: 
Azafaros begins subject enrolment in Phase II RAINBOW trial of AZ-3102
snippet: 

Azafaros has enrolled the first participant in its Phase II RAINBOW trial of AZ-3102 in GM2 gangliosidosis and Niemann-Pick disease type C (NP-C) patients.

Do Not Allow Advertisers to Use My Personal information